Skip to main content
. 2012 Feb 29;120(6):817–823. doi: 10.1289/ehp.1104395

Table 3.

Adjusteda ORs and 95% CI of high phobic anxiety (CCI ≥ 4) by bone lead tertile.

All women (n = 599; 1,100 assessmentsb) Premenopausal or postmenopausal on HRTc (n = 140; 261 assessments)
Lead biomarkers CCI ≥ 4 (yes/no) OR (95% CI) CCI ≥ 4 (yes/no) OR (95% CI)
Tibia lead tertile (μg/g)
< 7.0 78/288 Reference 11/73 Reference
7.0–11.5 66/265 0.84 (0.54, 1.32) 21/83 1.52 (0.60, 3.82)
> 11.5 100/303 1.10 (0.73, 1.64) 20/53 2.79 (1.02, 7.59)
p-Trend 0.62 0.05
Patella lead tertile (μg/g)
< 8.5 80/270 Reference 16/71 Reference
8.5–14.5 78/254 0.96 (0.63, 1.47) 26/64 1.16 (0.41, 3.28)
> 14.5 86/330 0.75 (0.49, 1.16) 10/74 0.23 (0.07, 0.69)
p-Trend 0.17 0.003
aAdjusted for substudy group, age at bone lead and at CCI measurement, education, husband’s education, alcohol consumption, pack-years of smoking, and employment status at CCI measurement. bOnly 1,098 for patella lead analyses because of missing patella lead data. cWomen who were either premenopausal at the time of bone lead measurement (n = 45) or consistently on HRT between menopause and bone lead measurement (n = 97).